Ranking reprogramming factors for cell differentiation

被引:0
|
作者
Jennifer Hammelman
Tulsi Patel
Michael Closser
Hynek Wichterle
David Gifford
机构
[1] Computational and Systems Biology,Departments of Pathology and Cell Biology, Neuroscience, Rehabilitation and Regenerative Medicine (in Neurology)
[2] MIT,Center for Motor Neuron Biology and Disease
[3] Computer Science and Artificial Intelligence Laboratory,Department of Biological Engineering
[4] MIT,Department of Electrical Engineering and Computer Science
[5] Columbia University Irving Medical Center,undefined
[6] Columbia University Irving Medical Center,undefined
[7] Columbia Stem Cell Initiative,undefined
[8] Columbia University Irving Medical Center,undefined
[9] MIT,undefined
[10] MIT,undefined
来源
Nature Methods | 2022年 / 19卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Transcription factor over-expression is a proven method for reprogramming cells to a desired cell type for regenerative medicine and therapeutic discovery. However, a general method for the identification of reprogramming factors to create an arbitrary cell type is an open problem. Here we examine the success rate of methods and data for differentiation by testing the ability of nine computational methods (CellNet, GarNet, EBseq, AME, DREME, HOMER, KMAC, diffTF and DeepAccess) to discover and rank candidate factors for eight target cell types with known reprogramming solutions. We compare methods that use gene expression, biological networks and chromatin accessibility data, and comprehensively test parameter and preprocessing of input data to optimize performance. We find the best factor identification methods can identify an average of 50–60% of reprogramming factors within the top ten candidates, and methods that use chromatin accessibility perform the best. Among the chromatin accessibility methods, complex methods DeepAccess and diffTF have higher correlation with the ranked significance of transcription factor candidates within reprogramming protocols for differentiation. We provide evidence that AME and diffTF are optimal methods for transcription factor recovery that will allow for systematic prioritization of transcription factor candidates to aid in the design of new reprogramming protocols.
引用
收藏
页码:812 / 822
页数:10
相关论文
共 50 条
  • [1] Ranking reprogramming factors for cell differentiation
    Hammelman, Jennifer
    Patel, Tulsi
    Closser, Michael
    Wichterle, Hynek
    Gifford, David
    [J]. NATURE METHODS, 2022, 19 (07) : 812 - +
  • [2] Novel factors for cell differentiation and reprogramming
    Wu, Jiarui
    [J]. JOURNAL OF MOLECULAR CELL BIOLOGY, 2014, 6 (05) : 355 - 355
  • [3] Metabolic reprogramming in skeletal cell differentiation
    Joshua CBertels
    Guangxu He
    Fanxin Long
    [J]. Bone Research, 2024, 12 (03) : 539 - 554
  • [4] A biomaterial approach to cell reprogramming and differentiation
    Long, Joseph
    Kim, Hyejin
    Kim, Dajeong
    Lee, Jong Bum
    Kim, Deok-Ho
    [J]. JOURNAL OF MATERIALS CHEMISTRY B, 2017, 5 (13) : 2375 - 2389
  • [5] Totipotency, cell differentiation and reprogramming in humans
    Hansis, Chris
    [J]. REPRODUCTIVE BIOMEDICINE ONLINE, 2006, 13 (04) : 551 - 557
  • [6] Signaling involved in stem cell reprogramming and differentiation
    Tanabe, Shihori
    [J]. WORLD JOURNAL OF STEM CELLS, 2015, 7 (07): : 992 - 998
  • [7] Microenvironmental and cell intrinsic factors governing human cDC2 differentiation and monocyte reprogramming
    Lang, Magdalena
    Krump, Corinna
    Meshcheryakova, Anastasia
    Tam-Amersdorfer, Carmen
    Schwarzenberger, Elke
    Passegger, Christina
    Connolly, Sally
    Mechtcheriakova, Diana
    Strobl, Herbert
    [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [8] Cancer Cell Reprogramming: Stem Cell Differentiation Stage Factors and An Agent Based Model to Optimize Cancer Treatment
    Biava, P. M.
    Basevi, M.
    Biggiero, L.
    Borgonovo, A.
    Borgonovo, E.
    Burigana, F.
    [J]. CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2011, 12 (02) : 231 - 242
  • [9] Pioneer transcription factors in cell reprogramming
    Iwafuchi-Doi, Makiko
    Zaret, Kenneth S.
    [J]. GENES & DEVELOPMENT, 2014, 28 (24) : 2679 - 2692
  • [10] MURINE SOMATIC CELL REPROGRAMMING TO PLURIPOTENCY AND DIFFERENTIATION INTO HEPATOCYTES
    de Alencastro, Gustavo
    Logan, Grant J.
    Smyth, Christine
    Studdert, Joshua B.
    Steiner, Kirsten A.
    Tam, Patrick P. L.
    Alexander, Ian E.
    [J]. JOURNAL OF GENE MEDICINE, 2011, 13 (7-8): : 432 - 433